247 related articles for article (PubMed ID: 32687852)
21. Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Nov; 383(19):e123. PubMed ID: 33211936
[No Abstract] [Full Text] [Related]
22. Remdesivir and Potential Interactions With Psychotropic Medications: A COVID-19 Perspective.
Mansuri Z; Shah B; Zafar MK; Jolly T; Jain S
Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32470232
[No Abstract] [Full Text] [Related]
23. Treatments for COVID-19: where are we now?
Mendes A
Br J Community Nurs; 2020 Aug; 25(8):412-413. PubMed ID: 32757900
[No Abstract] [Full Text] [Related]
24. Pharmacotherapy in COVID-19; A narrative review for emergency providers.
Mehta N; Mazer-Amirshahi M; Alkindi N; Pourmand A
Am J Emerg Med; 2020 Jul; 38(7):1488-1493. PubMed ID: 32336586
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
Hosoki K; Chakraborty A; Sur S
J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
[TBL] [Abstract][Full Text] [Related]
26. Idiopathic nonhistaminergic acquired angioedema in a patient with coronavirus disease 2019.
Azmy V; Benson J; Love K; Steele R
Ann Allergy Asthma Immunol; 2020 Nov; 125(5):600-602. PubMed ID: 32621992
[No Abstract] [Full Text] [Related]
27. Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
JAMA; 2020 Aug; 324(8):730-731. PubMed ID: 32777002
[No Abstract] [Full Text] [Related]
28. [From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic].
Estella Á; Garnacho-Montero J
Med Intensiva (Engl Ed); 2020 Nov; 44(8):509-512. PubMed ID: 32423569
[No Abstract] [Full Text] [Related]
29. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
Ison MG; Wolfe C; Boucher HW
JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438
[No Abstract] [Full Text] [Related]
30. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
Gupta SP
Curr Top Med Chem; 2020; 20(26):2362-2378. PubMed ID: 32962613
[TBL] [Abstract][Full Text] [Related]
31. Audio Interview: Studying Potential Covid-19 Therapies.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 May; 382(19):e72. PubMed ID: 32379957
[No Abstract] [Full Text] [Related]
32. Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19.
Chua KP; Conti RM
JAMA Intern Med; 2020 Oct; 180(10):1273-1274. PubMed ID: 32804187
[No Abstract] [Full Text] [Related]
33. Potential therapeutic targets and promising drugs for combating SARS-CoV-2.
Zhou H; Fang Y; Xu T; Ni WJ; Shen AZ; Meng XM
Br J Pharmacol; 2020 Jul; 177(14):3147-3161. PubMed ID: 32368792
[TBL] [Abstract][Full Text] [Related]
34. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
Wang D; Li Z; Liu Y
J Infect Public Health; 2020 Oct; 13(10):1405-1414. PubMed ID: 32684351
[TBL] [Abstract][Full Text] [Related]
35. Current pharmacological treatments for SARS-COV-2: A narrative review.
Nittari G; Pallotta G; Amenta F; Tayebati SK
Eur J Pharmacol; 2020 Sep; 882():173328. PubMed ID: 32603692
[TBL] [Abstract][Full Text] [Related]
36. The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications.
Ballout RA; Sviridov D; Bukrinsky MI; Remaley AT
FASEB J; 2020 Jun; 34(6):7253-7264. PubMed ID: 32367579
[TBL] [Abstract][Full Text] [Related]
37. A Proposed Lottery System to Allocate Scarce COVID-19 Medications: Promoting Fairness and Generating Knowledge.
White DB; Angus DC
JAMA; 2020 Jul; 324(4):329-330. PubMed ID: 32579158
[No Abstract] [Full Text] [Related]
38. The renin-angiotensin-aldosterone system: Role in pathogenesis and potential therapeutic target in COVID-19.
Braga CL; Silva-Aguiar RP; Battaglini D; Peruchetti DB; Robba C; Pelosi P; Rocco PRM; Caruso-Neves C; Silva PL
Pharmacol Res Perspect; 2020 Aug; 8(4):e00623. PubMed ID: 32658389
[TBL] [Abstract][Full Text] [Related]
39. [Not Available].
Fumeaux T
Rev Med Suisse; 2020 Jun; 16(697):1220. PubMed ID: 32520466
[No Abstract] [Full Text] [Related]
40. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
Sanders JM; Monogue ML; Jodlowski TZ; Cutrell JB
JAMA; 2020 May; 323(18):1824-1836. PubMed ID: 32282022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
